The costs associated with skin cancer increased five times as fast as treatments for other cancers between 2002 and 2011, according to a CDC study published online in the American Journal of...
Cancer Research UK scientists have discovered that melanoma cells are drawn to follow the 'trail' of a naturally-occurring molecule in the body, which directs this serious type of skin cancer to...
A new study claims cultural and historical factors over the past century, such as evolution of clothing trends and tanning perceptions, have contributed to rising melanoma rates.
GSK has announced updated results for Tafinlar® (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma.
A UCLA researcher at the Jonsson Comprehensive Cancer Center helped pioneer a new therapy that combines the drug Zelboraf® with an experimental drug cobimetinib, allowing metastatic melanoma...
Researchers at Lund University in Sweden and other institutions have worked out how the pigment of the skin manages to protect the body from the sun's dangerous UV rays.
GlaxoSmithKline (GSK) has announced that the National Institute for Health and Care Excellence (NICE) issued its final appraisal determination (FAD) recommending the use of Tafinlar®...
The early diagnosis and detection rates of skin cancer has been boosted by a pioneering digital application developed at the University of Edinburgh which trains the medical profession to...
According to a new medical literature review, pilots and cabin crew have approximately twice the incidence of developing melanomas compared with the general population.